ATR-CHK1 pathway as a therapeutic target for acute and chronic leukemias
Miroslav Boudný, Martin Trbušek
Topics & Concepts
MedicineMyeloid leukemiaLeukemiaIbrutinibChronic lymphocytic leukemiaVenetoclaxCancer researchDasatinibCancerImatinibImmunologyOncologyInternal medicineDNA Repair MechanismsAcute Lymphoblastic Leukemia researchCell death mechanisms and regulation